These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31792947)

  • 1. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
    McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
    J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing in older patients by early-career general practitioners: Prevalence and associations.
    Magin P; Quain D; Tapley A; van Driel M; Davey A; Holliday E; Ball J; Kaniah A; Turner R; Spike N; FitzGerald K; Hilmer S
    Int J Clin Pract; 2021 Aug; 75(8):e14325. PubMed ID: 33960089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
    McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
    PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
    Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
    JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomised controlled trial.
    Rieckert A; Reeves D; Altiner A; Drewelow E; Esmail A; Flamm M; Hann M; Johansson T; Klaassen-Mielke R; Kunnamo I; Löffler C; Piccoliori G; Sommerauer C; Trampisch US; Vögele A; Woodham A; Sönnichsen A
    BMJ; 2020 Jun; 369():m1822. PubMed ID: 32554566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study).
    Clyne B; Cooper JA; Hughes CM; Fahey T; Smith SM;
    Trials; 2016 Aug; 17(1):386. PubMed ID: 27488272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria.
    Curtin D; Jennings E; Daunt R; Curtin S; Randles M; Gallagher P; O'Mahony D
    J Am Geriatr Soc; 2020 Apr; 68(4):762-769. PubMed ID: 31868920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    BMJ Open; 2017 Apr; 7(4):e013800. PubMed ID: 28416498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacist integrated into a general practice in Australia: an evolving model of care in medicines optimization.
    Jordan M; Mullan J; Stewart A; Chen TF
    Int J Pharm Pract; 2023 Dec; 31(6):608-616. PubMed ID: 37823732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
    Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
    Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med study.
    Etherton-Beer C; Page A; Naganathan V; Potter K; Comans T; Hilmer SN; McLachlan AJ; Lindley RI; Mangin D
    Age Ageing; 2023 May; 52(5):. PubMed ID: 37247404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis.
    Okafor CE; Keramat SA; Comans T; Page AT; Potter K; Hilmer SN; Lindley RI; Mangin D; Naganathan V; Etherton-Beer C
    J Am Med Dir Assoc; 2024 Mar; 25(3):539-544.e2. PubMed ID: 38307120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.